Exacerbation of juvenile myoclonic epilepsy with lamotrigine

Neurology

Volumn 55, Issue 11, 2000, Pages 1758-

  Biraben, A ^a   Allain, H ^b   Scarabin, J M ^a   Schuck S ^b   Edan, G ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; SODIUM CHANNEL; TOPIRAMATE; VALPROIC ACID;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; GENERALIZED EPILEPSY; HUMAN; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0034642227     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.55.11.1757     Document Type: Article

References (5)

1. Lamotrigine in absence and primary generalized epilepsies
2. Double-blind, placebo controlled, crossover study of lamotrigine in treatment-resistant generalized epilepsy
3. Lamictal (lamotrigine) monotherapy for typical absences seizures in children
4. The use of lamotrigine in juvenile myoclonic epilepsy
5. Lamotrigine and seizure aggravation in severe myoclonic epilepsy